Please assess the completion status of the following clinical trial:

Trial Title: Hyperinvasive Approach in Cardiac Arrest

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* minimum of 18 and maximum of 65 years~* witnessed out-of-hospital cardiac arrest of presumed cardiac cause~* minimum of 5 minutes of ACLS performed by emergency medical service team without sustained ROSC~* unconsciousness (Glasgow Coma Score \< 8)~* ECMO team and bed-capacity in cardiac center available.~Exclusion Criteria:~* OHCA of presumed non-cardiac cause~* unwitnessed collapse~* pregnancy~* sustained ROSC within 5 minutes of ACLS performed by EMS team~* conscious patient~* known bleeding diathesis or suspected or confirmed acute or recent intracranial bleeding~* suspected or confirmed acute stroke~* known severe chronic organ dysfunction or other limitations in therapy~* do not resuscitate order or other circumstances making 180 day survival unlikely~* known pre-arrest cerebral performance category CPC ≥ 3.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Hyperinvasive arm (Type: EXPERIMENTAL): Hyperinvasive arm encompasses immediate institution of a mechanical chest compression device (LUCAS) and pre-hospital intraarrest cooling by Rhino-Chill device. Immediately after institution of these two devices the patients will be directly transferred to cardiac center cathlab under continuous CPR. The use of drugs and further defibrillations are on a discretion of the emergency physician. After admission to cathlab, overall status, ROSC presence and ECLS inclusion/exclusion criteria will be evaluated.
- Standard arm (Type: ACTIVE_COMPARATOR): Patients in standard arm will be further managed as per recent ERC guidelines, ie. continued ACLS. The use of drugs and further defibrillations are on a discretion of the emergency physician. If ROSC is attained, patients will be transferred to the same hospital to one of intensive care units, coronary angiography/PCI will be performed only if indicated according to routine practice and mild therapeutic hypothermia will be instituted as soon as possible as per recent guidelines recommendation.

Based on this trial design, predict the completion outcome and termination type (if applicable).